PW MEDTECH (01358) issued a statement on July 24, 2026, confirming that the company repurchased 60,000 shares of its own stock for a total of HK$62,400.
The buyback was executed at a per-share price of HK$1.04, reflecting the company's ongoing capital management strategy and commitment to shareholder value.